Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Leukemia 37Burkitt Lymphoma 13Lymphoma 9Leukemia, Biphenotypic, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 6Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Monocytic, Acute 3Down Syndrome 3Recurrence 2Neutropenia 2Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2Anemia, Refractory 2Thrombocytopenia 1Optic Nerve Glioma 1Lymphoma, T-Cell 1

Interventions

Cyclophosphamide 22blinatumomab 18Cytarabine 15fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Lenalidomide 7Dexamethasone 7Methotrexate 6Daunorubicin 6Mercaptopurine 5daratumumab 4Whole-Body Irradiation 4Vincristine 4Melphalan 4Idarubicin 4Etoposide 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Maintenance 3Immunotherapy, Adoptive 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Cladribine 3Asparaginase 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasm, Residual × Thioguanine × Clear all
NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡